Answers are grounded in this paper and cite their sources.
Glucagon-like peptide-1 receptor agonists (GLP-1 RA) have changed the landscape of type 2 diabetes (Τ2D) and, more recently, obesity treatment by providing significant long-term weight loss reac...
No takes yet. Share an insight, caveat, or question.
Apostolopoulou et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: